Combination of 5'-DFUR and MMC for recurrent rectal cancer with pulmonary metastasis
Ohtani, Y.; Ishikawa, H.; Aihara, S.; Kanazawa, H.; Hiki, Y.; Kakita, A.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 979-982
1999
ISSN/ISBN: 0385-0684 PMID: 10396327 Document Number: 504067
We report a 68-year-old man with rectal cancer and recurrent pulmonary metastasis treated with concomitant 5'-DFUR + MMC, which resulted in an extreme reduction of the lesion. The initial pulmonary metastases were treated by pneumonectomy, but 32 months later the patient again showed a pulmonary metastasis. Thus, from July 1997, he was treated with 5'-DFUR (800 mg/day) + MMC (4 mg/2 weeks). After 3 months of therapy, the chest CT examination showed an extreme reduction of the pulmonary lesion, and at 5 months the lesion was even smaller. Presently, after 7 months of therapy, the lesion remains stable. His CEA level is 1.0-2.6 ng/ml. After 4 months of treatment he had mild anorexia, which was alleviated by reducing the 5'-DFUR to 600 mg/day. No other adverse reaction was observed; the therapy was safely conducted on an outpatient basis.